A new research has revealed that daily dose of aspirin protects women over 65 against the cancer despite the dangers of internal bleeding.
The study at the University Medical Centre in the Netherlands also suggests that since younger women appear to gain no benefit, the regular use aspirin may be harmful for them, the Daily Express reported.
Although the possibility of developing serious illnesses, particularly cancer, and the risk of stomach bleeding rises with age, so too does the drug's impact on lowering the risk of bowel cancer and heart disease.
The study says that for over 65s, one case of cancer or heart disease and stroke would be prevented for every 29 aspirin users and on the other hand, blanket treatment regardless of age is ineffective or harmful in the majority of women.
Team leader Frank Visseren, said that for over 65s, aspirin only modestly lowers cardiovascular risk, while increasing the risk of major gastrointestinal bleeding, but the benefits for cancer could tip the balance in favour of aspirin in prevention.
The study is published online in the journal Heart.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
